Patents Examined by Karen E. Toth
  • Patent number: 12064242
    Abstract: A photometry device can include a first to emit light to a target in response to a first current through the first LED, a second LED to emit light to the target in response to a second current through the second LED, and an inductor, coupled to the first and second LEDs, to store energy associated with at least one of the first and second currents.
    Type: Grant
    Filed: April 21, 2020
    Date of Patent: August 20, 2024
    Assignee: Analog Devices International Unlimited Company
    Inventors: John Jude O'Donnell, Colin G. Lyden, Michael C. W. Coln
  • Patent number: 12059272
    Abstract: The application relates to a method for analyzing continuously monitored physiological measurement values of a user, the method being performed in a data processing system and comprising: providing, by a data interface, a set of present physiological measurement values, determining whether a common pattern of values is contained in both the set of present physiological measurement values and a set of historical physiological measurement values, if the common pattern of values is found, requesting the user to provide contextualization for at least the present physiological measurement values of the common pattern of values, receiving contextualization and storing contextualized data. Furthermore, the application relates to a device for analyzing continuously monitored physiological measurement values of a user.
    Type: Grant
    Filed: August 26, 2020
    Date of Patent: August 13, 2024
    Assignee: Roche Diabetes Care, Inc.
    Inventors: Bernd Steiger, Juergen Rasch-Menges
  • Patent number: 12029606
    Abstract: A medical device (20) includes a case (32), having a front surface that is configured to be brought into contact with a body of the living subject (24). A microphone (34) is contained in the case and configured to sense acoustic waves emitted from the body and to output an acoustic signal in response thereto. A proximity sensor (56) is configured to output a proximity signal indicative of contact between the front surface and the body. At least one speaker (49) is configured to output audible sounds. Processing circuitry (50) is coupled to detect, in response to the proximity signal, that the front surface is in contact with the body, and in response to the detected contact, to process the acoustic signal so as to generate an audio output and to convey the audio output to the at least one speaker.
    Type: Grant
    Filed: August 22, 2018
    Date of Patent: July 9, 2024
    Assignee: SANOLLA LTD.
    Inventors: Doron Adler, Igor Kagan, Ezra Salomon, Omri Adler, David Linhard
  • Patent number: 11980463
    Abstract: A blood glucose sensing system includes a sensor and a sensor electronics device. The sensor includes a plurality of electrodes. The sensor electronics device includes stabilization circuitry. The stabilization circuitry causes a first voltage to be applied to one of the electrodes for a first timeframe and causes a second voltage to be applied to one of the electrodes for a second timeframe. The stabilization circuitry repeats the application of the first voltage and the second voltage to continue the anodic—cathodic cycle. The sensor electronics device may include a power supply, a regulator, and a voltage application device, where the voltage application device receives a regulated voltage from the regulator, applies a first voltage to an electrode for the first timeframe, and applies a second voltage to an electrode for the second timeframe.
    Type: Grant
    Filed: August 7, 2019
    Date of Patent: May 14, 2024
    Assignee: MEDTRONIC MINIMED, INC.
    Inventors: Rajiv Shah, Bahar Reghabi, James L. Henke, Wayne A. Morgan, Gopikrishnan Soundararajan, David Y. Choy, Peter Schultz, Udo Hoss
  • Patent number: 11957488
    Abstract: A medical device includes a sensor to observe a characteristic of an anatomy, and a sensor base coupled to the sensor. The medical device includes a coupling system to couple the sensor base to the anatomy. The coupling system includes a first adhesive member and a second adhesive member. The first adhesive member is coupled to the sensor base and the second adhesive member is to couple to the anatomy. The first adhesive member includes at least one cut-out to direct moisture to an ambient environment surrounding the medical device.
    Type: Grant
    Filed: February 7, 2020
    Date of Patent: April 16, 2024
    Assignee: Medtronic Minimed, Inc.
    Inventors: Jasson Rodriguez, Ellis Garai, Ravi R. Deverkadra, Sara M. Voisin, Jacob E. Pananen
  • Patent number: 11950884
    Abstract: Embodiments of the present disclosure are configured to assess the severity of a blockage in a vessel and, in particular, a stenosis in a blood vessel. In some particular embodiments, the devices, systems, and methods of the present disclosure are configured to assess the severity of a stenosis in the coronary arteries without the administration of a hyperemic agent.
    Type: Grant
    Filed: February 5, 2021
    Date of Patent: April 9, 2024
    Assignees: PHILIPS IMAGE GUIDED THERAPY CORPORATION, IMPERIAL COLLEGE OF SCIENCE, TECHNOLOGY & MEDICINE, MEDSOLVE LIMITED
    Inventors: Justin Davies, Joseph Burnett, Neil Hattangadi, David Anderson, Helen Davies
  • Patent number: 11937916
    Abstract: A system and method for remotely monitoring an individual, in accordance with some embodiments of the invention. More particularly, one or more physiological functions and/or physical activities of the individual may be monitored. In order to monitor the individual, a range to, and/or a range rate (i.e., velocity) of, one or more points on one or more surfaces of the individual (e.g., skin, clothing, lips, etc.) may be determined over time. Based on the determinations of the range and/or range rate of the points on the surfaces of the individual, the one or more physiological functions and/or physical activities of the individual may be monitored. This may enable the physiological functions and/or physical activities to be monitored remotely from the individual without access or proximity to the individual.
    Type: Grant
    Filed: February 15, 2021
    Date of Patent: March 26, 2024
    Assignee: Aeva, Inc.
    Inventors: Richard Lee Sebastian, Kendall L. Belsley
  • Patent number: 11937901
    Abstract: An arteriovenous fistula (AVF) stenosis detection system and method thereof and sensing device are provided. The AVF stenosis detection system includes: a sensing device including a microphone; and a server coupled to the sensing device. The sensing device contacts a first location of a patient body, wherein there is a first distance between the first location and a second location of an AVF of the patient body, and the first location is located on an extended path of an artery or a vein corresponding to the AVF. The sensing device receives a frequency spectrum signal through the microphone and transmits the frequency spectrum signal to the server. The server calculates a stenosis percentage of the AVF corresponding to the frequency spectrum signal through a machine learning module and transmits the stenosis percentage to the sensing device.
    Type: Grant
    Filed: April 19, 2019
    Date of Patent: March 26, 2024
    Assignee: Above Care Inc.
    Inventors: Wei-Ta Chen, Yung-Hsin Chen
  • Patent number: 11918349
    Abstract: Disclosed herein are techniques related to model predictive control. The techniques may involve generating a desired glucose trajectory that approaches a desired steady state setpoint from a current glucose value over a prediction horizon. The techniques may involve generating a plurality of insulin delivery patterns. Each insulin delivery pattern may correspond to an amount of insulin to be delivered over a control horizon. The techniques may involve generating a plurality of predicted glucose trajectories over the control horizon. Each predicted glucose may be generated based on the current glucose value and a respective insulin delivery pattern. The techniques may involve comparing the desired glucose trajectory against each predicted glucose trajectory and selecting a predicted glucose trajectory that is more similar to the desired glucose trajectory than any other predicted glucose trajectory.
    Type: Grant
    Filed: October 29, 2020
    Date of Patent: March 5, 2024
    Assignee: MEDTRONIC MINIMED, INC.
    Inventors: Garry M. Steil, Sami S. Kanderian, Jr., Martin T. Cantwell, Udo Hoss
  • Patent number: 11877829
    Abstract: A system and method for characterising a narrowing in a fluid filled tube, the system comprising: a probe having a first measurement sensor to take an instantaneous measurement at different locations along the tube; a mechanism to draw the probe through the tube; a position measure to provide location data relating to the location at which a respective instantaneous measurement is taken by the first measurement sensor; a processor to calculate, from the instantaneous measurements, a characteristic of the tube at different locations along the tube.
    Type: Grant
    Filed: November 22, 2021
    Date of Patent: January 23, 2024
    Assignee: MEDSOLVE LIMITED
    Inventors: Helen Catherine Stuart Davies, Justin Davies
  • Patent number: 11864722
    Abstract: Methods and systems for adjusting ventilator settings in a patient based on information obtained by measuring anatomical dead space VD in a lung are provided utilizing controlled indicator gas delivery over multiple breaths, including related measurements and calculations of lung inhomogeneity, functional residual capacity, avelolar volume VA, dead space VD, and pulmonary blood flow {dot over (Q)}P.
    Type: Grant
    Filed: September 29, 2020
    Date of Patent: January 9, 2024
    Assignee: VENTDX, INC.
    Inventors: Phi Anh Phan, Andrew Farmery, Clive Hahn
  • Patent number: 11850066
    Abstract: A system and method for measuring and monitoring blood pressure is provided. The system includes a wearable device and a tonometry device coupled to the wearable device. The Tonometry device is configured to compress a superficial temporal artery (STA] of a user. A sensor pad is attached to the wearable device adjacent the tonometry device. A blood pressure sensor is integrated within the sensor pad for continuous, unobtrusive blood pressure monitoring.
    Type: Grant
    Filed: October 31, 2014
    Date of Patent: December 26, 2023
    Assignee: The General Hospital Corporation
    Inventors: Quan Zhang, Yuanting Zhang
  • Patent number: 11832937
    Abstract: An injector for transcutaneously introducing a sensor into a patient, including a cannula, a sensor arranged in the cannula, a base element, a sliding element arranged displaceably on the base element in an injection direction, for transcutaneously introducing the cannula having the sensor into the patient in an injection operation. The cannula has a slot in a longitudinal direction of the cannula. The injector has a holding element arranged displaceably on the base element that, in an ejection operation, prevents the sensor from being pulled out as the cannula is withdrawn, by engaging in a distal end region of the sensor through the slot into the cannula. The holding element and/or base element have at least one fixing arrangement to automatically lock the holding element on the base element when the cannula is introduced transcutaneously into the patient. A method for transcutaneously introducing a sensor into a patient is also provided.
    Type: Grant
    Filed: January 22, 2019
    Date of Patent: December 5, 2023
    Assignee: EYESENSE GMBH
    Inventors: Achim Muller, Tom Meissner-Braun, Matthias Pischan
  • Patent number: 11832970
    Abstract: Systems and methods for monitoring patients for risk of worsening heart failure (WHF) are discussed. A patient management system includes a sensor circuit to receive respiration measurements, and an input device to receive patient dyspnea descriptor indicating dyspnea symptom severity. The system includes a risk analyzer circuit to trend the respiration measurement over time, and to generate a WHF risk indicator using both the trended respiration measurement and the received dyspnea descriptor. A control circuit controls the receiver circuit to receive the dyspnea descriptor in response to the trended respiration measurement satisfying a specific condition. The system can present the WHF risk indicator to a user or a process, or deliver or adjust a HF therapy based on the WHF risk indicator.
    Type: Grant
    Filed: July 26, 2018
    Date of Patent: December 5, 2023
    Assignee: Cardiac Pacemakers, Inc.
    Inventors: Qi An, Pramodsingh Hirasingh Thakur, Yi Zhang, Viktoria A Averina
  • Patent number: 11806134
    Abstract: In some embodiments, a sensor assembly for a continuous glucose monitoring system is provided that includes (1) a sensor carrier having a sensor unit receiving area and an electronics receiving area, the electronics receiving area including a substrate; (2) a sensor unit having a sterilized region, the sterilized region including at least a portion of a sensor and an introducer; and (3) electronics for the continuous glucose monitoring system. The sensor unit is positioned within the sensor unit receiving area of the sensor carrier and the electronics are positioned on the substrate within the electronics receiving area of the sensor carrier so as to form a sensor assembly having the sensor electrically connected to the substrate of the electronics receiving area while maintaining sterilization of the sterilized region of the sensor unit. Numerous other aspects are provided.
    Type: Grant
    Filed: May 8, 2018
    Date of Patent: November 7, 2023
    Assignee: Ascensia Diabetes Care Holdings AG
    Inventors: Eugene Prais, Jennifer L. Gass, Nihir Patel, Nikhil M. Shah
  • Patent number: 11801344
    Abstract: Disclosed are a system, methods and computer-readable medium products that provide bolus dosage calculations by a control algorithm-based drug delivery system that provides automatic delivery of a drug, such as insulin or the like, based on sensor input. Blood glucose measurement values may be received at regular time intervals from a sensor. Using the blood glucose measurements, the control algorithm may perform various calculations and determinations to provide an appropriate bolus dosage. The appropriate bolus dosage may be used to respond to a trend in a trajectory of blood glucose measurements. In addition, a bolus dosage may also be determined by the disclosed device, system, method and/or computer-readable medium product in response to an indication that a user consumed a meal.
    Type: Grant
    Filed: September 13, 2019
    Date of Patent: October 31, 2023
    Assignee: INSULET CORPORATION
    Inventors: Steven Cardinali, Joon Bok Lee, Jason O'Connor, Yibin Zheng
  • Patent number: 11751778
    Abstract: A sensor apparatus for a continuous glucose monitoring system has a sensor housing that includes a first end having a sealing surface configured to seal against an introducer having an insertion shaft, a second end having a sealing surface configured to seal against an insertion shaft cover, and an insertion shaft opening having a width that allows the insertion shaft to travel there through and that extends between the first and second ends. The sensor housing may further include a sensor wire channel that extends between the insertion shaft opening and a sensor wire contact location in an outer surface of the sensor housing. The sensor wire channel and sensor wire contact location may be configured to receive a sensor that extends between the insertion shaft opening and the sensor wire contact location to allow the sensor to make electrical contact to system circuitry. Numerous other aspects are provided.
    Type: Grant
    Filed: April 11, 2019
    Date of Patent: September 12, 2023
    Assignee: Ascensia Diabetes Care Holdings AG
    Inventors: Cameron M. Young, Jennifer L. Gass, Thomas A. J. Mayer, Jr., Eugene Prais
  • Patent number: 11723559
    Abstract: In some embodiments, a sensor assembly for a continuous glucose monitoring system is provided that includes (1) a sensor carrier having a sensor unit receiving area and an electronics receiving area, the electronics receiving area including a substrate; (2) a sensor unit having a sterilized region, the sterilized region including at least a portion of a sensor and an introducer; and (3) electronics for the continuous glucose monitoring system. The sensor unit is positioned within the sensor unit receiving area of the sensor carrier and the electronics are positioned on the substrate within the electronics receiving area of the sensor carrier so as to form a sensor assembly having the sensor electrically connected to the substrate of the electronics receiving area while maintaining sterilization of the sterilized region of the sensor unit. Numerous other aspects are provided.
    Type: Grant
    Filed: May 8, 2018
    Date of Patent: August 15, 2023
    Assignee: Ascensia Diabetes Care Holdings AG
    Inventors: Eugene Prais, Jennifer L. Gass, Nihir Patel, Nikhil M. Shah
  • Patent number: 11690528
    Abstract: Methods and systems are disclosed for the detecting of whether a subject has a lung disorder such as asthma, tuberculosis or lung cancer. Monitoring the subject's health and prognosis is also disclosed.
    Type: Grant
    Filed: February 14, 2020
    Date of Patent: July 4, 2023
    Assignee: TricornTech Taiwan
    Inventors: Li-Peng Wang, Chi-Lin Young, Chien-Lin Huang, Tsung-Kuan A. Chou
  • Patent number: 11672445
    Abstract: An injector for transcutaneously introducing a sensor into a patient, including a cannula, a base element, a sliding element arranged displaceably on the base element, for transcutaneously introducing the cannula into the patient in an injection direction, and including an ejection element for automatically pulling the cannula out of the patient counter to the injection direction by the ejection element in an ejection operation. The injector has a locking element for the ejection element such that, in a delivery state, the ejection element is lockable in an energy-charged state, and the sliding element and the locking element are configured to interact indirectly or directly in order, in an injection state, when the cannula is introduced transcutaneously into the patient, to release the locking of the ejection element in order automatically to start the ejection operation.
    Type: Grant
    Filed: January 22, 2019
    Date of Patent: June 13, 2023
    Assignee: EyeSense GmbH
    Inventors: Achim Muller, Tom Meissner-Braun, Matthias Pischan